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Letter to the Editor
Response letter to T Fowler and
co-authors – estimating the positive
predictive value of opportunistic
population testing for gonorrhoea as part
of the English Chlamydia Screening
Programme
Dear Editor,
Fowler et al.1 discuss the inclusion of gonorrhoea
screening alongside the National Chlamydia Screening
Programme (NCSP) in one part of the UK and the
calculation of positive predictive values (PPVs) to
guide commissioning decisions. This is a timely and
welcome contribution given the increased deployment
of ‘dual testing’ – where nucleic acid ampliﬁcation tests
(NAAT) simultaneously test for chlamydia and gonor-
rhoea using the same sample.
However, we have concerns about some of the
assumptions used when estimating PPVs, particularly
the assertion that sensitivity and speciﬁcity may vary by
prevalence, which is not substantiated in the context of
asymptomatic gonorrhoea testing. Although some stu-
dies have shown that sensitivity and speciﬁcity may vary
byprevalence, this relates todiﬀeringdisease severity and
diagnostic deﬁnitions.2 In most disease processes, diag-
nosis becomes more certain as the disease progresses and
it is intuitive that diagnostic test performance should
improve with progression, the so-called spectrum bias.3
However, opportunistic testing in non-symptomatic
individuals is diﬀerent; this represents a homogenous
group. There is no reason to believe that the sensitivity
and speciﬁcity will systematically vary with the underly-
ing prevalence of an asymptomatic sexually transmitted
infection (STI). Furthermore, the absolute diﬀerence
in diagnosed gonorrhoea prevalence quoted is small;
35 per 100,000 in Greater Manchester versus 28 per
100,000 in England, and any diﬀerence in PPV is unlikely
to make testing in one area viable and not in another.
We agree with the authors’ emphasis on the import-
ance of conﬁrmatory NAAT testing following a react-
ive screen for gonorrhoea, which supports current
national gonorrhoea testing guidance.4 They also
suggest restricting gonorrhoea testing in low prevalence
areas to those with a positive chlamydia test. However,
where dual testing is used in the NCSP, the chlamydia
test result would be unknown at the point of gonor-
rhoea testing, and it is already the case that the
NCSP core requirements recommend a full STI screen
(including gonorrhoea, syphilis and HIV testing) for all
patients diagnosed with chlamydia as part of routine
clinical management.5
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